dye 
Sponsors
Southwest Hospital, Army Medical University
Conditions
Breast Cancer
Early Phase 1
A single-center prospective clinical randomized controlled trial for indocyanine green replacement nuclide for sentinel lymph node combined development in breast cancer
RecruitingChiCTR1900022938
Start: 2019-05-06Updated: 2019-05-05
Indocyanine green substitute nuclide for sentinel lymph node combined development in breast cancer: a single-center prospective self-controlled clinical study
RecruitingChiCTR2000030729
Start: 2020-03-02Updated: 2020-03-16